These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3111633)
1. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs. Scolding N Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1551-2. PubMed ID: 3111633 [No Abstract] [Full Text] [Related]
2. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial. Walker MG; Shaw JW; Thomson GJ; Cumming JG; Thomas ML Br Med J (Clin Res Ed); 1987 May; 294(6581):1189-92. PubMed ID: 3109574 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous or intravenous heparin for deep vein thrombosis. Bounameaux H; Krahenbuhl B Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1690-1. PubMed ID: 3113593 [No Abstract] [Full Text] [Related]
4. Subcutaneous compared with intravenous heparin for deep vein thrombosis. Moser KM; Fedullo PF Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616225 [No Abstract] [Full Text] [Related]
5. Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study. Robinson AM; McLean KA; Greaves M; Channer KS Postgrad Med J; 1993 Feb; 69(808):115-6. PubMed ID: 8506190 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous compared with intravenous heparin for deep vein thrombosis. Burnum JF Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616224 [No Abstract] [Full Text] [Related]
7. Subcutaneous compared with intravenous heparin for deep vein thrombosis. Young MA Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616226 [No Abstract] [Full Text] [Related]
8. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of deep venous thrombosis with fixed doses of subcutaneous heparin. Preliminary results]. Lastória S; Maffei FH; Rollo HA; Yoshida WB; Castiglia V; Lorenzi LC; Lintz JA; Sanchez MA AMB Rev Assoc Med Bras; 1983; 29(11-12):188-90. PubMed ID: 6608754 [No Abstract] [Full Text] [Related]
10. Treatment of venous thrombosis with subcutaneous heparin. Salzman EW N Engl J Med; 1982 Jan; 306(4):232-4. PubMed ID: 7054685 [No Abstract] [Full Text] [Related]
11. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities]. Lopaciuk S; Misiak A; Wisławski S; Ciesielski L; Korzycki J; Judkiewicz L; Lewandowski K; Tokarz A; Kłoczko J; Bielawiec M Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):949-52. PubMed ID: 2104438 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792 [TBL] [Abstract][Full Text] [Related]
13. [Heparin treatment. Comparison between intravenous and subcutaneous administration]. Krähenbühl B; Simon CA; Bouvier CA; Schinas P; Hopf MA; Cochet B Schweiz Med Wochenschr; 1979 Sep; 109(36):1322-5. PubMed ID: 504973 [TBL] [Abstract][Full Text] [Related]
14. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group. Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388 [TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. Hommes DW; Bura A; Mazzolai L; Büller HR; ten Cate JW Ann Intern Med; 1992 Feb; 116(4):279-84. PubMed ID: 1531108 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial. Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531 [TBL] [Abstract][Full Text] [Related]
19. Heparin and deep venous thrombosis. Routledge PA; Scolding NJ Ann Intern Med; 1988 Mar; 108(3):488-9. PubMed ID: 3341689 [No Abstract] [Full Text] [Related]